Ładuje się......
Updated report on tools to measure outcomes of clinical trials in fragile X syndrome
OBJECTIVE: Fragile X syndrome (FXS) has been the neurodevelopmental disorder with the most active translation of preclinical breakthroughs into clinical trials. This process has led to a critical assessment of outcome measures, which resulted in a comprehensive review published in 2013. Nevertheless...
Zapisane w:
| Wydane w: | J Neurodev Disord |
|---|---|
| Główni autorzy: | , , , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
BioMed Central
2017
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5467057/ https://ncbi.nlm.nih.gov/pubmed/28616097 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s11689-017-9193-x |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|